BackLegend Biotech Overview
Legend Biotech Corp - ADR

Legend Biotech Target Price

Where could LEGN trade next? Consensus target price: $56.

Get informed when a big investor buys or sells

+ Follow

Share Price

$21.52

Average Target Price

$55.58158.3% upside

12 analysts in the last 4 months

High: $78 | Low: $28

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-04Morgan Stanley$65202% upsideOpen
2026-08-12Oppenheimer$4085.9% upsideOpen
2026-08-12Barclays$78262.5% upsideOpen
2026-07-27Raymond JamesSean McCutcheon$58169.5% upsideOpen
2026-07-27RBC Capital$59174.2% upsideOpen
2026-07-24UBS$2830.1% upsideOpen
2026-07-07RBC CapitalLeonid Timashev$63192.8% upsideOpen
2026-06-03UBSAshwani Verma$49127.7% upsideOpen
2026-06-03H.C. Wainwright$65202% upsideOpen
2026-06-01UBS$50132.3% upsideOpen
2026-05-13RBC CapitalLeonid Timashev$64197.4% upsideOpen
2026-05-13Morgan StanleyTerence Flynn$48123% upsideOpen
2026-03-11Morgan Stanley$49127.7% upsideOpen
2026-03-11RBC Capital$62188.1% upsideOpen
2026-03-10Truist FinancialAsthika Goonewardene$70225.3% upsideOpen
2026-03-10JefferiesCui Cui$69220.6% upsideOpen
2026-02-12Redburn PartnersQize Ding$2411.5% upsideOpen
2026-01-22H.C. Wainwright$50132.3% upsideOpen
2026-01-22Jefferies$212.4% downsideOpen
2026-01-20RBC Capital$66206.7% upsideOpen
2026-01-07Oppenheimer$75248.5% upsideOpen
2025-12-17Cantor Fitzgerald$74243.9% upsideOpen
2025-12-12Morgan Stanley$50132.3% upsideOpen
2025-12-08RBC CapitalLeonid Timashev$74243.9% upsideOpen
2025-12-08UBSAshwani Verma$48123% upsideOpen
2025-10-17Johnson Rice$60178.8% upsideOpen
2025-07-02UBSAshwani Verma$54150.9% upsideOpen
2025-03-12H.C. WainwrightMitchell Kapoor$75248.5% upsideOpen
2024-11-13Cantor FitzgeraldRick Bienkowski$83285.7% upsideOpen
2024-10-15BTIGJustin Zelin$91322.9% upsideOpen
2024-10-15Johnson RiceGena Wang$94336.8% upsideOpen
2024-10-15BarclaysGena Wang$94336.8% upsideOpen
2024-10-08Redburn PartnersQize Ding$86299.6% upsideOpen
2024-06-17Piper SandlerEdward Tenthoff$90318.2% upsideOpen
2024-06-17Truist FinancialAsthika Goonewardene$88308.9% upsideOpen
2024-05-23Deutsche BankJames Shin$60178.8% upsideOpen
2024-05-17Morgan StanleyMatthew Harrison$82281% upsideOpen
2024-05-14RBC CapitalLeonid Timashev$86299.6% upsideOpen
2024-04-17ScotiabankGeorge Farmer$65202% upsideOpen
2024-04-03Cantor FitzgeraldRick Bienkowski$82281% upsideOpen
2024-03-14BMO CapitalKostas Biliouris$90318.2% upsideOpen
2022-12-06UBS$66206.7% upsideOpen

Legend Biotech (LEGN) FAQ

Legend Biotech's target price stands at $56. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $56 for LEGN implies 158.3% upside versus today's price ($21.52). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Legend Biotech's target price evolved across reporting periods, while the comparison chart places LEGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Legend Biotech's reading of $56 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.